• magic wand
    Image attribution tooltip
    Stock via Getty Images

    What would you fix with a ‘magic wand’? Pharma leaders chime in about clinical trials

    How life science execs would transform clinical trials with a little hocus pocus.

    By PharmaVoice staff • March 24, 2023
  • Mayank Anand, vice president and global head of data strategy and management, GSK
    Image attribution tooltip
    Permission granted by GSK

    This GSK clinical data leader embraces the ‘Rubik’s cube’ problem: solving for all sides at once

    The clinical data space is rapidly changing the face of the industry, GSK's Mayank Anand said — and the way organizations adopt technology is a critical part of the equation.

    By March 23, 2023
  • test tube gene Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images

    Cell and gene therapies

    How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.

    By PharmaVoice staff
  • High angle shot of people reaching to connect puzzle pieces together
    Image attribution tooltip
    Stock via Getty Images

    Everyone says they’re patient-centric, but have they really walked the walk?

    Life science leaders provide practical tips on how to create a sustainable patient-focused culture.

    By March 23, 2023
  • wuhan
    Image attribution tooltip
    Getty via Getty Images

    Viral roots: A look at how modern outbreaks began

    As experts wrestle with COVID-19’s lab leak versus animal market debate, here’s what experts say are the suspected origins for some of the worst viral outbreaks in the last century.

    By March 22, 2023
  • A person stands outside of a building that says 'Silicon Valley Bank' with their hand on their chin.
    Image attribution tooltip
    Justin Sullivan via Getty Images

    SVB’s collapse had limited impact on biopharmas — but a broader financial crisis could change the landscape

    Although many pharma and biotech companies had deposits at the failed bank, most have reported little to no exposure.

    By March 21, 2023
  • Living room interior with tv and sofa back view at night.
    Image attribution tooltip

    ShutterStock / klyaksun

    Sponsored by Adheris Health

    Changing the channel from TV to the pharmacy boosts DTC ROI

    While a TV spot still has its allure, the level of engagement provided through the pharmacy channel is more than a little compelling.

    By Heather Campbell, VP Marketing, Adheris Health • March 20, 2023
  • A glass building with a sign that reads,  "Biogen."
    Image attribution tooltip

    Paul Marotta/Sipa USA/Newscom

    Making Moves

    In the fallout from Aduhelm, Biogen’s leadership shakeup continues

    The recent departure of neurodegenerative development head Samantha Budd Haeberlein is just the latest sign of a changing tide among Biogen’s post-Aduhelm leadership.

    By March 16, 2023
  • A man walks out of the Pfizer world headquarters building.
    Image attribution tooltip
    Chris Hondros / Staff via Getty Images

    Return of the megadeal: Pfizer’s Seagen buy has the industry asking if super-sized M&A is back

    A $43 billion deal that doubles the pharma giant's cancer pipeline shows that M&A is back on the table in pharma.

    By March 16, 2023
  • leadership
    Image attribution tooltip
    Stock via Getty Images
    PharmaVoice 100

    The PharmaVoice 100 — Who makes the cut

    What we’re looking for in each new class of honorees.

    By March 15, 2023
  • Chris Fox Novartis Gene Therapies
    Image attribution tooltip
    Permission granted by Chris Fox Novartis Gene Therapies

    Woman of the Week: Novartis Gene Therapies’ Chris Fox

    Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. When Novartis acquired AveXis and its spinal muscular atroph...

    By March 15, 2023
  • Christiane Langer
    Image attribution tooltip
    Permission granted by BeiGene

    A rising oncology powerhouse in China, BeiGene looks to strengthen its international punch

    To expand its reach, Christiane Langer, the company’s head of medical affairs, is leaning on connections and singularity over fitting in a box.

    By March 14, 2023
  • U.S. President Joe Biden speaking in Philadelphia.
    Image attribution tooltip
    Chip Somodevilla/Staff/Getty Images News via Getty Images

    Biden doubles down on drug pricing in 2024 budget — but boosts R&D

    The president’s 2024 budget proposal expands on last year’s drug pricing reforms, but also dramatically increases innovation investments.

    By March 13, 2023
  • Pharmacist talking with customer about medicine bottle in drugstore.
    Image attribution tooltip
    simonkr via Getty Images
    Sponsored by GoodRx

    Across therapy areas, GoodRx’s POS rebates improve access and affordability for cash-paying patients

    Across therapy areas, GoodRx Assist is a proven point-of-sale rebate program for cash-paying patients.

    March 13, 2023
  • Murray Aitken IQVIA Institute
    Image attribution tooltip
    Permission granted by Murray Aitken/IQVIA Institute

    IQVIA’s OG of data analytics on the latest clinical trial trends

    IQVIA Institute’s Murray Aitken is the man behind the numbers, and here, shares the newest findings on clinical trial burnout, diversity and more.

    By March 10, 2023
  • Neuroscience
    Image attribution tooltip
    iStock via Getty Images

    Janssen neuroscience leader takes on rare diseases one small ‘eureka’ at a time

    Fueled by a fascination with the scientific process, Sindhu Ramchandren is exploring how a new drug could treat patients with a range of rare diseases.

    By March 9, 2023
  • Senior older women
    Image attribution tooltip
    Stock via Getty Images

    Targeting the new ‘Golden Girls’

    With unprecedented buying power, women over 50 wield a lot of influence — but are still underserved by pharma. Urovant hopes to change that with its potential blockbuster drug.

    By March 8, 2023
  • storytelling marketing
    Image attribution tooltip
    Stock via Getty Images

    3 keys to good storytelling in pharma

    The CEO of Complement Therapeutics shares simple storytelling tactics lead to maximum impact.

    By Alexandra Pecci • March 7, 2023
  • Concept image of insulin aspart with fake labeling
    Image attribution tooltip
    Samara Heisz via Getty Images

    Eli Lilly took price cuts into its own hands. Will other pharmas follow suit?

    The pharma giant took the high road and cut prices before the feds made them. How will that affect the industry?

    By March 7, 2023
  • Colorful medical pills cover Benjamin Franklin's face on one hundred american dollar bill.
    Image attribution tooltip
    Stock via Getty Images

    FDA ups generics and biosimilar approvals for a shot at lower drug costs

    As the Biden administration searched for drug-cost reducing measures, the FDA incentivized generic and biosimilar development in 2022. 

    By March 6, 2023
  • layoffs
    Image attribution tooltip
    Stock via Getty Images

    Why layoffs are not the answer to biopharma’s troubled market

    As companies look to cut costs, an EY analyst urges them to consider not cutting staff.

    By Kelly Bilodeau • March 6, 2023
  • A female patient is sitting on the examination table during a medical check up with a doctor
    Image attribution tooltip
    FatCamera via Getty Images
    Sponsored by GoodRx

    Biosimilar insights to help marketers navigate the year ahead

    Bracing for biosimilars? Learn how biosimilar launches differ from traditional biologics.

    March 6, 2023
  • silhouette people
    Image attribution tooltip
    Stock via Getty Images

    PharmaVoice 100 honorees: Where are they now?

    How some of our past PharmaVoice 100 honorees are transforming the life sciences industry in new roles. 

    By , March 3, 2023
  • Cindy Dunkle Denali Therapeutics
    Image attribution tooltip
    Permission granted by Cindy Dunkle Denali Therapeutics

    Woman of the Week: Denali Therapeutics’ Cindy Dunkle

    As chief people officer, Dunkle is harnessing the company’s unique culture to foster innovation.

    By March 1, 2023
  • pharma lab cropped
    Image attribution tooltip
    Stock via Getty Images

    Do R&D costs justify the price of drugs? Nope, new study says

    A BMJ study found that spending on drug sales vastly outstripped spending on drug development.

    By Alexandra Pecci • March 1, 2023
  • A sign for the Food and Drug Administration is seen on July 20, 2020 in Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images

    Reata’s stock plummets amid sudden FDA neuro office shakeup

    The FDA’s longtime neuroscience head Billy Dunn stepped down, leaving industry reeling over how the agency’s new acting director could handle upcoming approval decisions.

    By Feb. 28, 2023